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Background: Eriosema laurentii De Wild. (Leguminosae) is a plant used in Cameroon against infertility and
gynecological or menopausal complaints. In our previous report, a methanol extract of its aerial parts was
shown to exhibit estrogenic and aryl hydrocarbon receptor agonistic activities in vitro and to prevent
menopausal symptoms in ovariectomized Wistar rats.
Methods: In order to determine the major estrogen receptor α (ERα) agonists in the extract, an activity-guided
fractionation was performed using the ERα yeast screen. To check whether the ERα active fractions/compounds
also accounted for the aryl hydrocarbon receptor (AhR) agonistic activity of the crude methanol extract, they
were further tested on the AhR yeast screen.
Results: This study led to the identification of 2′-hydroxygenistein, lupinalbin A and genistein as major estrogenic
principles of the extract. 2′-hydroxygenistein and lupinalbin A were, for the first time, also shown to possess an AhR
agonistic activity, whereas genistein was not active in this assay. In addition, it was possible to deduce structure-activity
relationships.
Conclusions: These results suggest that the identified compounds are the major active principles responsible for the
estrogenic and AhR agonistic activities of the crude methanol extract of the aerial parts of Eriosema laurentii.
Keywords: Eriosema laurentii de Wild., Yeast transactivation assays, Estrogen receptor α, Aryl hydrocarbon receptor,
Genistein, 2′-Hydroxygenistein, Lupinalbin ABackground
Plants from the Leguminosae family are well known for
their medicinal properties and are used for different
purposes in connection with women’s reproductive
function, bone density, cardiovascular health and cancer
prevention. Their therapeutic effects are very often
attributed to the estrogen-like phytoconstituents known
as phytoestrogens. For instance, the health benefits of
soybeans (Glycine max L.) and red clover (Trifolium
pratense L.) on menopause-related health problems
have frequently been ascribed to their high isoflavone
content [1-3]. Phytoestrogen exposure occurs primarily* Correspondence: liselotte.krenn@univie.ac.at
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and these compounds display estrogenic properties due
to the binding to estrogen receptors in target cells.
Beside estrogen receptors, phytoestrogens can also directly
or indirectly modulate a wide range of signaling pathways,
including the aryl hydrocarbon receptor (AhR) [5,6].
Although the effect of this receptor on the reproduct-
ive physiology is not yet fully understood, studies have
reported its involvement in several antiestrogenic
activities [7-9].
Eriosema laurentii De Wild. (Leguminosae) is widely
distributed in West and Central Africa where it is used as
traditional remedy and food [10]. In Cameroon, E. lauren-
tii preparations are used for the treatment of infertility
and various gynecological and menopausal complaints.
Our previous study showed that the methanol extract oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Ateba et al. BMC Complementary and Alternative Medicine 2014, 14:294 Page 2 of 10
http://www.biomedcentral.com/1472-6882/14/294the aerial parts of E. laurentii exhibited agonistic activities
at the estrogen receptor α and the aryl hydrocarbon re-
ceptor in yeast transactivation assays and prevented
menopause-related symptoms induced by ovariectomy
in rats [11]. In addition, the safety profile of this extract
indicated a broad safety margin following acute and
subchronic oral administration [12]. Therefore, in order
to identify the chemical constituents responsible for the
observed estrogenic and AhR agonistic activities, an
activity-guided fractionation was performed using the
ERα- and AhR-yeast assays on recombinant Saccharomy-
ces cerevisiae strains.
Methods
General experimental procedures
Solvents for extraction and fractionation (analytical grade)
as well as HPLC-grade acetonitrile (Chromanorm) and
methanol (LiChrosolv) were obtained from VWR Inter-
national (West Chester, Pennsylvania, USA). Glacial
acetic acid (Rotichrom) was purchased from Carl Roth
(Karlsruhe, Germany). Genistein (HPLC quality) for the
dereplication approach was purchased from Sigma-Aldrich
(St. Louis, Missouri, USA).
Plant material
Aerial parts of E. laurentii were collected at July 10th,
2010 in Bazou, West Region of Cameroon. The plant
was identified and authenticated by Mr. Victor Nana,
botanist at the Cameroon National Herbarium, where a
voucher specimen has been deposited under the number
24480/SRF/Cam.
Preparation of the extract and fractionation
The air-dried and pulverized aerial parts of E. laurentii
(2.5 kg) were extracted with 95% methanol at room
temperature (3 × 5 L of solvent; 48 h per extraction). The
combined solutions were concentrated by evaporation
(40°C) to afford 130 g of the methanol extract (=AEL)
(Figure 1). The extract (in two portions of 60 g, each)
was subjected to vacuum liquid chromatography (column:
5 × 50 cm) on silica gel under successive elution with pet-
roleum ether, petroleum ether-CHCl3 (1:1, v/v), CHCl3,
CHCl3-MeOH (1:1, v/v), MeOH and MeOH-H2O (7:3, v/v)
using 2000 mL of each solvent. The eluates obtained from
the two columns with the same solvent were pooled and
evaporated to give petroleum ether (=PEAL, 0.26 g), petrol-
eum ether-CHCl3 (=PCAL, 0.53 g), CHCl3 (=CAL, 1.53 g),
CHCl3-MeOH (=CMAL, 67.32 g), MeOH (=MAL, 24.3 g)
and MeOH-H2O (=MWAL, 4.8 g) fractions. Sixty seven
grams of the CMAL fraction, which was the only active
one in estrogen receptor α yeast assay (yERα), were
further fractionated by liquid-liquid partition using
petroleum ether-water (1:1,v/v) to afford a water-soluble
part (=W-CMAL, 29 g), a petroleum ether-soluble part(=P-CMAL, 11 g) and a non-soluble part (=S-CMAL,
25 g). The most active fraction S-CMAL (22 g) was
suspended in CHCl3-isopropanol (3:2, v/v) and partitioned
with an equal volume of water. The CHCl3-isopropanol
fraction (=Ci, 17.7 g) was applied to Sephadex LH-20
column chromatography (4 × 50 cm, 15 mL/30 min) and
eluted with 80% MeOH to yield eleven fractions (F1-F11)
combined according to their TLC profile. F7 (529 mg)
was further subjected to a Sephadex LH-20 column
chromatography (2 × 50 cm, 5 mL/20 min) and eluted
with 70% MeOH to yield 8 subfractions (SF1-SF8). By
crystallization, SF7 (108 mg) yielded lupinalbin A (21
mg), whereas genistein was identified in SF5 using a
dereplication approach by TLC and HPLC-DAD. The ac-
tive fraction W-CMAL was partitioned with n-BuOH-H2O
(1:1, v/v) and the n-BuOH soluble material (=Bu, 7.5 g) was
further chromatographed on Sephadex LH-20 (4 × 50 cm;
10 mL/30 min) and eluted with MeOH-H2O mixtures
under increasing amounts of MeOH (40% to 80%) to yield
31 combined fractions (CF1-CF31). CF21 (1.3 g) was sus-
pended in EtOAc and the supernatant was evaporated to
yield 2′-hydroxygenistein (250 mg).
Identification of the major active compounds
The isoflavonoids lupinalbin A and 2′-hydroxygenistein
were unambiguously identified by UV, MS, 1H and 13C
NMR; genistein and other components of the extract by
TLC-, HPLC- and MS-comparison with authentic ma-
terial (Figure 2). HPLC-UV analysis was performed on
a Shimadzu Prominence HPLC system with a Luna
5μm C18 (2) 100Å (250 × 4.60 mm I.D.) column by a
HPLC method previously described [11]. LC-MS was
conducted on an UltiMate 3000RSLC-series system
(Dionex, Germering, Germany) coupled to an HCT 3D
quadrupole ion trap mass spectrometer equipped with
an orthogonal ESI source (Bruker Daltonics, Bremen,
Germany). HPLC separation in LC-MS experiments was
carried out on a Luna 5μm C18 (2) 100Å (250 × 4.60 mm
I.D.) column at 25°C using water (adjusted to pH 3.0 with
acetic acid) as mobile phase A and acetonitrile/mobile
phase A 4:1 (v/v) as mobile phase B. The flow rate was 1.0
mL/min and the following two gradient programs were
used for the analysis of selected fractions and isolated
compounds:
Gradient 1: 5% B (0 min), 5% B (5 min), 20% B
(15 min), and 20% B (30 min)
Gradient 2: 20% B (0 min), 20% B (5 min), 34% B
(10 min), 34% B (30 min), and 36.4% B (37.5 min)
Each gradient was followed by a column cleaning and
re-equilibration step. The eluent flow was split in a 1:4
ratio before the ESI ion source, which was operated as
follows: capillary voltage: ±3.7 kV, nebulizer: 26 psi (N2),
Figure 1 Scheme of extraction and fractionation of the methanol extract of the aerial parts of Eriosema laurentii. * Percent yield on dry
weight basis of crude methanol extract.
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MS2, MS3, and MS4 spectra were obtained in an auto-
mated data-dependent acquisition mode (collision gas:
He, isolation window: 4 Th, fragmentation amplitude:
1.0 V).
The nuclear magnetic resonance (NMR) data were
recorded at 298.2 K on a Bruker Avance DRX 600 in-
strument operating at 600.13 MHz for 1H and 150.91
MHz for 13C, respectively. The 1H- and 13C-NMR data
of lupinalbin A and 2′-hydroxygenistein are shown in
Table 1 and the MS data for all three compounds are
given below. The spectroscopic data were in good correl-
ation to published data (see Table 1) [13,14].
2′-Hydroxygenistein: +ESIMS m/z 287.0 [M + H]+;
+ESIMS2 (287.0→) m/z 271.0 (8), 268.9 (8), 259.0
(27), 244.9 (35), 230.9 (19), 216.9 (100), 202.9 (11),189.0 (16), 175.0 (34), 161.0 (23), 153.0 (95), 149.0 (34),
137.0 (11); -ESIMS m/z 284.9 [M-H]−; -ESIMS2
(284.9→) m/z 240.9 (6), 216.9 (100), 198.9 (8), 174.9 (6).
Lupinalbin A: +ESIMS m/z 285.0 [M + H]+; +ESIMS2
(285.0 →) m/z 256.9 (100), 228.9 (23), 212.9 (10), 185.0
(12), 173.0 (6); +ESIMS3 (285.0 → 256.9 →) m/z 228.9
(100), 173.2 (7); -ESIMS m/z 282.9 [M-H]−; -ESIMS2
(282.9 →) m/z 265.8 (8), 264.8 (17), 254.9 (100), 238.9
(24), 236.9 (7), 226.9 (10), 214.9 (8), 210.9 (8), 172.9
(7); -ESIMS3 (282.9→ 254.9 →) m/z 236.8 (6), 226.9
(100), 210.9 (14), 182.9 (10).
Genistein: +ESIMS m/z 271.0 [M + H]+; +ESIMS2
(271.0 →) m/z 253.0 (9), 242.9 (12), 215.0 (25), 153.0
(100), 149.0 (11), 147.1 (37), 145.0 (8).
The chemical structures of these 3 major compounds
are depicted in Figure 3.
For MS identification of other compounds see Table 2.
Figure 2 HPLC-DAD chromatogram (254 nm) of the methanol extract of aerial parts of E. laurentii. Peak letters refer to the identified
compounds (see Table 2).
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Disodium hydrogen phosphate dihydrate (Na2HPO4 ·
2H2O), potassium chloride (KCl), magnesium sulfate
heptahydrate (MgSO4 · 7H2O), sodium carbonate (Na2CO3)
and ammonium sulfate ((NH4)2SO4) were obtained from
Merck (Darmstadt, Germany). Sodium dihydrogen phos-
phate dihydrate (NaH2PO4 · 2H2O), N-lauroylsarcosine
(Sarkosyl), o-nitrophenol-β-galactopyranoside (ONPG),
DL-dithiothreitol (DTT), dimethylsulfoxide (DMSO), D-(+)
glucose, estradiol, 5α-dihydroxytestosterone, genistein,Table 1 1H- and 13C-NMR data of lupinalbin A and 2′-hydroxy
Lupinalbin A
Position 1H (ppm) JH,H (Hz)
13C (ppm) 13C (pp
2 C — 166.22
3 C — 98.65
4 C — 180.06
4a C — 104.47
5 C — 164.04
6 CH 6.281 (d 2.2) 100.92
7 C — 165.32
8 CH 6.483 (d 2.2) 95.83
8a C — 156.59
1′ C — 115.23
2′ C — 151.95
3′ CH 7.007 (d 2.0) 99.51
4′ C — 157.81
5′ CH 6.903 (dd 2.0/8.5) 114.67
6′ CH 7.780 (d 8.5) 122.52progesterone, and β-naphthoflavone were purchased from
Sigma-Aldrich (St. Louis, Missouri, USA). Yeast nitrogen
base was obtained from Difco (Franklin Lakes, New
Jersey, USA), amino acids from Serva Feinbiochemica
(Heidelberg, Germany), dropout medium without trypto-
phan (DO-trp) from Sigma-Aldrich, and dropout supple-
ment media without tryptophan and uracile (CSM-trp-ura)
from MP Biomedicals.
LacZ-buffer was composed of 60mM Na2HPO4 · 2H2O,
40mM NaH2PO4 · 2H2O, 10mM KCl, 1mM MgSO4 ·genistein (in CD3OD)as compared with literature [13,14]
2′-Hydroxygenistein
m) [13] 1H (ppm) JH,H (Hz)
13C (ppm) 13C (ppm) [14]
166.2 7.866 154.78 155.7
99.5 — 122.24 120.8
180.0 — 181.59 180.8
104.5 — 104.87 104.8
164.0 — 161.85 162.3
100.9 6.258 (d 2.2) 99.69 99.3
165.2 — 164.54 164.7
95.8 6.335 (d 2.2) 94.07 94.0
156.6 — 158.04 158.1
114.7 — 110.51 109.0
151.9 — 158.89 156.8
98.7 6.424 (d 2.0) 104.87 103.0
157.8 — 156.29 159.0
115.2 6.412 (dd 2.0/8.5) 108.31 106.6
122.5 6.955 (d 8.5) 130.91 132.6
Figure 3 Chemical structures of 2′-hydroxygenistein, genistein and lupinalbin A.
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N-lauroyl-sarcosine was dissolved in LacZ-buffer with
2mM DTT.
The estrogenic and aryl hydrocarbon receptor agonis-
tic activities were assessed using recombinant Saccharo-
myces cerevisiae yeast strains 188R1 and YCM3. The
estrogen yeast assay is a two-plasmid system containing
an expression plasmid with the human ERα gene and a
LacZ reporter plasmid. The construct of the AhR yeast
assay contains beside a LacZ reporter plasmid, the
human AhR and aryl hydrocarbon receptor nuclear
translocator (ARNT) genes integrated in chromosome
III. Assay performance and data evaluation have been
described previously [5,15].
Briefly, 1 μL of sample was added in 100 μL of yeast
culture (OD600 = 0.4) and incubated at 30°C for 5 h and
17 h for ERα and AhR, respectively. After incubation cells
were disintegrated by adding 150 μL 2 mM Z-sarcosyl-
buffer, the OD600 measured and the microtiter plate incu-
bated at 30°C for 20 min for the complete disintegration. In
each well, 50 μL of o-nitrophenyl β-D-galactopyranoside
(4 mg/mL in lacZ-buffer) were added and the plate was
incubated at 37°C till the development of yellow color.
Afterwards, the reaction was stopped by adding 50 μL 1M
Na2CO3, the total reaction time noted and the absorption
measured at 405 nm (reference wavelength 620 nm).
Statistical analysis
Data are expressed as means of three independent dupli-
cate experiments ± standard deviation (SD) and analyzedTable 2 Compounds assigned in the extracts of E. laurentii by
Peak Rt (min) UV λmax(MeOH) (nm) Molecular for
a 11.89 257sh, 269, 349 C21H20O1
b 14.08 270, 337 C21H20O1
c 15.09 254, 348 C21H20O1
d 15.69 260, 325sh C21H20O1
e 28.89 258 C15H10O6
f 32.48 254, 266sh, 349 C15H10O6
g 33.60 255, 369 C15H10O7
h 38.61 255, 357 C16H12O7
i 43.85 260 C15H10O5
j 51.22 256, 281,334 C15H8O6using Student’s t-test. Results were considered significant
when p ≤ 0.05.
Results and discussion
In order to identify the major compounds responsible
for the estrogenic activity of the methanol extract of the
aerial parts of E. laurentii, an activity-guided fraction-
ation was performed as described in more detail above
(Figure 1).
The CHCl3-MeOH fraction (CMAL) of the methanol
extract from the aerial parts of E. laurentii was the only
fraction that exhibited estrogenic activity. The three
subfractions from CMAL (P-CMAL, S-CMAL and W-
CMAL) also induced a dose-dependent and significant
β-galactosidase activity in estrogen receptor α yeast
assay (yERα) from 1 μg/mL (p ≤ 0.05) compared with
DMSO (Figure 4A). Fraction S-CMAL showed the
strongest effect, and at the dose of 2.5 μg/mL this
fraction exhibited a magnitude of response comparable
to that of estradiol at the dose of 10 nM. In contrast,
the petroleum fraction (P-CMAL) was the weakest
one. S-CMAL appeared to be about 10-20 fold more
potent than CMAL, whereas the weight of CMAL was
only about 2.5-fold the weight of S-CMAL. Plant extracts/
fractions contain combinations of different phytochemi-
cals that can interact in a very complex manner leading
to antagonistic/synergistic or additive mechanisms. Their
fractionation can thus disrupt these molecular interactions
resulting in an increase, decrease or abolishment of
potency. In such a scenario, the modest potency ofHPLC-DAD and HPLC/ESI-MS
mula Identification Class
1 Isoorientin Flavone
0 Isovitexin Flavone
1 Luteolin-7-O-glucoside Flavone
0 Genistin Isoflavone
2′-hydroxygenistein Isoflavone
Luteolin Flavone
Quercetin Flavonol
Quercetin-3-O-methylether Flavonol
Genistein Isoflavone
Lupinalbin A Coumaronochromone
Figure 4 Normalized Miller Units of CMAL and its sub-fractions in the estrogen receptor α yeast assay. DMSO: dimethyl sulfoxide, E2:
17β-estradiol, A) CMAL: chloroform/methanol fraction of the methanol extract of aerial parts of Eriosema laurentii, W-CMAL: aqueous phase of
CMAL, S-CMAL: non-soluble part of CMAL, P-CMAL: petroleum ether phase of CMAL, B) Bu: n-butanol fraction of W-CMAL, C) Ci: chloroform-isopropanol
fraction of S-CMAL and F7: subfraction 7 of Ci. Data are expressed as mean ± standard deviation of three independent experiments performed in duplicate.
*p≤ 0.05, **p≤ 0.01 and ***p≤ 0.001 versus DMSO.
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to the presence of some antagonistic interactions in
CMAL. Another reason for the high activity of S-CMAL
was the occurrence of genistin in the fraction. This com-
pound was removed by partition in the aqueous fraction
(see Figure 1).
Fraction Bu of W-CMAL also induced a β-galactosidase
activity in the ERα yeast assay (Figure 4B) and its fraction-
ation yielded 2′-hydroxygenistein (250 mg) as the major
component. Fraction Ci of S-CMAL increased the ERα
activity in a significant and dose-dependent manner
(p ≤ 0.05) starting from 0.1 μg/mL. Its magnitude of
activity at 1 μg/mL equals that of estradiol at 0.5-1 nM.
Moreover, the fraction 7 of Ci (F7) was about a factor
of ten more potent than fraction Ci (Figure 4C). From
this subfraction, lupinalbin A (21 mg) was isolated. The
identification of lupinalbin A and 2′-hydroxygenistein wasperformed by MS- and one and two-dimensional NMR-
experiments. Data showed good correlation with literature
(see Table 1). Genistein, one of the major constituents of
E. laurentii as reported previously [11], was identified
using a dereplication approach by TLC, LC-DAD and MS.
As shown in Figure 5, genistein, 2′-hydroxygenistein and
lupinalbin A induced a dose-dependent β-galactosidase
activity in the ERα yeast two-hybrid assay. According to
the dose-response curves, the EC50 values of genistein,
2′-hydroxygenistein and lupinalbin A were 0.32 μM,
6.1 μM and 21.4 nM, respectively, whereas that of 17β-
estradiol was 0.27 nM. In line with these results, all
three compounds displayed the maximal efficacy of the
standard endogenous hormone 17β-estradiol, suggest-
ing that they may be considered as full ERα agonists.
On the other hand, it appears that the 2′-hydroxylation
of genistein reduced its potency by 19-fold. In contrast,
Figure 5 Dose-response curves of 2′-hydroxygenistein, lupinalbin A and genistein in the estrogen receptor α yeast assay. Mean values
of at least three independent experiments performed in duplicates are shown with standard deviations.
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genistein was approximately 15-fold more potent than
genistein.
In order to check whether the ERα-active fractions/
compounds identified in the methanol extract of E.
laurentii also accounted for the aryl hydrocarbon re-
ceptor (AhR) agonistic activity of the crude methanol
extract, they were additionally tested on the AhR yeast
screen. According to our results, the tested fractions
also showed AhR agonistic properties (Figure 6). As in
the ERα yeast screen, S-CMAL was the most potent
fraction of CMAL (Figure 6A). In comparison to CMAL,
it was more potent and activated the AhR already at 2.5
μg/mL in the same manner (p ≤ 0.001) as the reference
compound β-naphthoflavone at 20 nM (=EC50). Fraction
Bu (from W-CMAL) as well induced a significant and
dose-dependent activity of AhR already starting from
1 μg/mL. Its activity at 10-25 μg/mL equaled that of
β-naphtho-flavone at 20 nM (Figure 6B). Similarly,
fraction Ci and its sub-fraction F7 induced a notable
AhR activity compared with DMSO (Figure 6C). Fraction
Ci induced a significant (p ≤ 0.05) β-galactosidase activity
starting from 0.5 μg/mL. At 10-50 μg/mL, the magnitude
of activity of Ci was the same as β-naphthoflavone at its
EC50-value. Sub-fraction F7 from Ci had the same effect
already at 0.05-0.1 μg/mL. A growing body of evidence
indicates that AhR/ERα interactions greatly impact the
gene expression and proliferative programs of estrogen-
sensitive cancers cells. Research addressing this crosstalkshowed repressive effects of ligands of AhR on ERα in the
estrogen-induced proliferative responses in endometrium
and breast cancer cells [16-19]. In respect with this, the
activated AhR has been reported to increase the metabol-
ism of E2 via the expression of cytochrome P450 enzymes
(CYP1A1 and CYP1B1) [20] and to induce the ubiquiti-
nation and proteasomal degradation of ERα in rodent
tumors and in ZR-75, T47D, and MCF-7 human breast
cancer cells [21,9]. This degradation of ERα was signifi-
cantly higher after co-treatment (co-activation) with E2
and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) than
after treatment with TCDD alone [9]. AhR can also in-
hibit ER-dependent transcriptional activities either by
binding to the inhibitory xenobiotic response elements
(iXRE) located in some ER-dependent promoters (pro-
moter interference) or by the competition for a common
pool of co-activators [8]. In addition, knockdown of AhR
abrogates the repression of estrogen-dependent gene tran-
scription in MCF-7 breast cancer and ECC-1 endometrial
carcinoma cells [22] as well as in the development of
colonic tumors in the cecum [23]. According to several
reports, these repressive effects of AhR on cancer are
mediated by the presence of exogenous ligands of AhR
[24,25]. Our results show that some fractions of E.
laurentii activated the AhR and thus, active constituents
may be considered as exogenous ligands of this receptor.
Given these repressive mechanisms of AhR on ERα signal-
ing pathways and due to the coexistence of both receptors
in estrogen-sensitive tissues including breast, uterus and
Figure 6 Normalized Miller Units of CMAL and its sub-fractions in the aryl hydrocarbon receptor yeast assay. DMSO: dimethyl sulfoxide,
b-NF: β-naphthoflavone, A) CMAL: chloroform/methanol fraction of the methanol extract of aerial parts of Eriosema laurentii, W-CMAL: aqueous
phase of CMAL, S-CMAL: non-soluble part of CMAL, P-CMAL: petroleum ether phase of CMAL, B) Bu: n-butanol fraction of W-CMAL, C) Ci:
chloroform-isopropanol fraction of S-CMAL and F7: subfraction 7 of Ci. Data are expressed as mean ± standard deviation of three independent
experiments performed in duplicate. *p≤ 0.05, **p≤ 0.01 and ***p ≤ 0.001 versus DMSO.
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AhR could be of physiologic and anti-tumorigenic rele-
vance. However, besides these anti-estrogenic effects of
AhR, data in literature are quite conflicting regarding the
implication of AhR in cancer promotion or prevention. It
has also been related to cancer initiation or progression
via the expression of CYP 450 enzymes (CYP1A1/2 and
CYP1B1). The expression of CYP1A1 is part of negative
feedback mechanisms regulating the AhR; by metaboliza-
tion and agonist depletion, CYP1A1 prevents a constitu-
tive activation of the AhR pathway. If this mechanism is
impaired the AhR pathway is dysfunctional and toxic
responses are the consequence [26]. Uno et al. observed
in CYP1A1 knockout mice that although benzo[a]pyrene
is metabolized by CYP1A1 to a carcinogenic epoxid form,
in the absence of CYP1A1 acute benzo[a]pyrene toxicity
is more fatal [27]. Nowadays, CYP1A1 is known to bepredominantly important for detoxication of carcinogens
and metabolic activation of dietary compounds with
cancer preventive activity [28,29] whereas CYP1B1 is
implicated in the metabolic activation of procarcinogens
causing DNA adducts formation [30]. In respect with
this, up-regulation of CYP1A1 vs. CYP1B1 (detoxication/
procarcinogen activation) appears to be an indispensable
precondition for tumor prevention. However, the under-
lying mechanisms that modulate this balance still remain
unclear depending on the AhR agonists, cell context as
well as co-regulators present in different cell types. There-
fore, although several constituents of E. laurentii are AhR
agonists, a final conclusion about their contribution to
cancer prevention or progression is not possible, yet.
As far as the isolated compounds are concerned, 2′-
hydroxygenistein and lupinalbin A were found to be
active in the AhR yeast assay (Figure 7). The EC50 value
Figure 7 Dose-response curves of 2′-hydroxygenistein, lupinalbin A and genistein in the aryl hydrocarbon receptor yeast assay. Mean
values of at least three independent experiments performed in duplicates are shown with standard deviations.
Ateba et al. BMC Complementary and Alternative Medicine 2014, 14:294 Page 9 of 10
http://www.biomedcentral.com/1472-6882/14/294of lupinalbin A was 1.34 μM while the one of 2′-hydro-
xygenistein was not determined because a saturation of
the receptor was not achieved. To the best of our
knowledge, these compounds have not been previously
associated with any AhR activity. According to our
results, genistein was not active, which is in agreement
to previous data obtained with the same yeast system
by Medjakovic and Jungbauer [5]. Thus, it appears that
hydroxylation at C-2′ of genistein as well as constraining
ring B to the benzopyran core by an oxygen bridge are
responsible for the observed AhR agonistic activity. Given
the maximal efficacy, these compounds may be considered
as partial agonists of AhR.
Conclusions
The activity-guided fractionation of the crude methanol
extract of aerial parts of Eriosema laurentii lead to the
identification of components with estrogenic and aryl
hydrocarbon receptor agonistic activities. Genistein, 2′-
hydroxygenistein and lupinalbin A, which were identified
in or isolated from the most active fractions, were found
to be full agonists of ERα. Furthermore, we provide the
first report of an agonistic activity of lupinalbin A and
2′-hydroxygenistein towards the AhR, whereas genistein
remained without effect at the AhR. The results enabled
the deduction of structure-activity relationships for AhR
agonistic activity between these compounds for the first
time as well. Thus, the data presented in this studyconfirmed that these phytoconstituents contribute to
the estrogenic and aryl hydrocarbon receptor agonistic
activities of the extract of Eriosema laurentii and might
partly account to the beneficial effects of the methanol
extract in vivo.
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